Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
0.890
+0.044 (5.24%)
At close: Apr 28, 2026, 4:00 PM EDT
0.888
-0.003 (-0.28%)
After-hours: Apr 28, 2026, 7:01 PM EDT
Rockwell Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 69.26 | 101.49 | 83.61 | 72.81 | 61.93 | |
| Revenue Growth (YoY) | -31.76% | 21.38% | 14.84% | 17.57% | -0.43% | |
| Cost of Revenue | 57.56 | 84.01 | 74.91 | 68.73 | 64.35 | |
| Gross Profit | 11.7 | 17.48 | 8.7 | 4.08 | -2.42 | |
| Selling, General & Admin | 16.39 | 16.86 | 14.27 | 17.74 | 21.08 | |
| Research & Development | - | 0.02 | 1.11 | 3.12 | 6.84 | |
| Operating Expenses | 16.39 | 16.88 | 15.37 | 20.86 | 27.92 | |
| Operating Income | -4.69 | 0.61 | -6.67 | -16.78 | -30.34 | |
| Interest Expense | -1.12 | -1.25 | -2.3 | -1.94 | -2.36 | |
| Interest & Investment Income | 0.23 | 0.09 | 0.21 | 0.03 | 0.02 | |
| EBT Excluding Unusual Items | -5.58 | -0.55 | -8.76 | -18.68 | -32.67 | |
| Gain (Loss) on Sale of Investments | 0.27 | 0.07 | 0.32 | 0 | - | |
| Pretax Income | -5.31 | -0.48 | -8.44 | -18.68 | -32.67 | |
| Net Income | -5.31 | -0.48 | -8.44 | -18.68 | -32.67 | |
| Preferred Dividends & Other Adjustments | 0.15 | 0.3 | 0.15 | - | - | |
| Net Income to Common | -5.47 | -0.78 | -8.59 | -18.68 | -32.67 | |
| Shares Outstanding (Basic) | 36 | 31 | 23 | 14 | 9 | |
| Shares Outstanding (Diluted) | 36 | 31 | 23 | 14 | 9 | |
| Shares Change (YoY) | 15.83% | 33.17% | 63.05% | 67.77% | 24.02% | |
| EPS (Basic) | -0.15 | -0.03 | -0.37 | -1.31 | -3.83 | |
| EPS (Diluted) | -0.15 | -0.03 | -0.37 | -1.31 | -3.83 | |
| Free Cash Flow | -1.2 | 3.19 | -9.7 | -17.21 | -34.06 | |
| Free Cash Flow Per Share | -0.03 | 0.10 | -0.42 | -1.20 | -3.99 | |
| Gross Margin | 16.89% | 17.23% | 10.41% | 5.60% | -3.91% | |
| Operating Margin | -6.77% | 0.60% | -7.98% | -23.05% | -48.98% | |
| Profit Margin | -7.89% | -0.77% | -10.27% | -25.65% | -52.76% | |
| Free Cash Flow Margin | -1.73% | 3.14% | -11.60% | -23.64% | -54.99% | |
| EBITDA | -2.5 | 2.79 | -5.23 | -16.2 | -29.67 | |
| EBITDA Margin | -3.61% | 2.75% | -6.25% | -22.25% | -47.91% | |
| D&A For EBITDA | 2.19 | 2.18 | 1.44 | 0.58 | 0.67 | |
| EBIT | -4.69 | 0.61 | -6.67 | -16.78 | -30.34 | |
| EBIT Margin | -6.77% | 0.60% | -7.98% | -23.05% | -48.98% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.